Please join us at the Royal Free Hospital in June. We will be discussing a paper that attempts to quantify the advantages GeneXpert can bring over empiric treatment in low burden settings, with respect to over treatment and unnecessary rehousing or contact tracing.
Paper: Davis et al. Impact of GeneXpert MTB/RIF® on Patients and Tuberculosis Programs in a Low-Burden Setting: A Hypothetical Trial. Am J Respir Crit Care Med 2014 [Epub ahead of print, available here].
Presenter: Tino Capocci, Research Registrar in Respiratory Medicine, Royal Free Hospital.
Chair: Marc Lipman, Department of Medicine, UCL
Time: 4-5pm, Thursday 26 June (with beers in a local pub afterwards).
Venue: Tutorial Room 1 (TR1), Lower Ground Floor, Royal Free Hospital.
Tutorial Room 1 is on the Lower Ground Floor at the Royal Free Hospital. For a more detailed view, please click on the map. For directions to the Royal Free Hospital, please click here.
North London TB Journal Club 
This is the perfect blog for anybody who wants to
understand this topic. You understand a whole lot its almost hard to argue with you (not that I actually
would want to…HaHa). You certainly put a new spin on a topic that has been discussed for
a long time. Wonderful stuff, just wonderful!